Abstract

To date, there are no effective methods of treating Cryptosporidium infection in animals or humans. Matrine, a main active alkaloid extract from Sophora flavescens, has potential antineoplastic, antifibrotic, anti-inflammatory, and antitumor activities. However, the treating effects of matrine on Cryptosporidium infection as well as its mechanisms of action are largely unknown. The present study investigated the effects of matrine on Cryptosporidium parvum infection in both in vitro and in vivo models. Oocyst excretion, plasma D-lactic acid concentrations, and bacterial translocation rates were assayed to evaluate the efficacy of treatment in experimentally infected BALB/c mice. Matrine effects on parasite replication and lactate dehydrogenase (LDH) activity were assessed in cell cultures. The results showed that matrine could significantly reduce the number of C. parvum oocysts by 54-63%, and the number of C. parvum-infected cells by 28-58%. Plasma D-lactic acid concentrations and LDH activity in the matrine-treated groups were lower than the infected group (P < 0.05) and higher than the control (P < 0.05). The bacterial translocation rates in groups treated with matrine at high doses were lower than the infected group (P < 0.05) and not higher than the control (P > 0.05). These results clearly demonstrate that matrine can inhibit C. parvum infection. Integrity of cell membranes and of the mucosal barrier is improved in treated animals as compared to untreated infected controls. Thus, it is concluded that matrine has a potential in therapeutic applications against C. parvum infection.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.